1. Thermo-Transient Receptor Potential Channels: Therapeutic Potential in Gastric Cancer
   Gang-Fan Zong et al, 2022, International Journal of Molecular Sciences CrossRef
2. p22phox confers resistance to cisplatin, by blocking its entry into the nucleus
   Chih-Chang Hung et al, 2015, Oncotarget CrossRef
3. Oncogenes: The Passport for Viral Oncolysis through PKR Inhibition
   Janaina Fernandes, 2016, Biomarkers in Cancer CrossRef
4. PFKFB4 negatively regulated the expression of histone acetyltransferase GCN5 to mediate the tumorigenesis of thyroid cancer
   Huanquan Lu et al, 2020, Development, Growth & Differentiation CrossRef
5. Molecular Signaling Pathways Involved in Gastric Cancer Chemoresistance
   Henu Kumar Verma et al, 2020, Theranostics Approaches to Gastric and Colon Cancer CrossRef
6. RLN2 Is a Positive Regulator of AKT-2-Induced Gene Expression Required for Osteosarcoma Cells Invasion and Chemoresistance
   Jinfeng Ma et al, 2015, BioMed Research International CrossRef
7. Combination effects of arsenic trioxide and fibroblast growth factor receptor inhibitor in squamous cell lung carcinoma
   Sze-Kwan Lam et al, 2016, Lung Cancer CrossRef
8. Cisplatin: an old drug with a newfound efficacy – from mechanisms of action to cytotoxicity
   Antonio Macciò et al, 2013, Expert Opinion on Pharmacotherapy CrossRef
9. SCARA3 inhibits cell proliferation and EMT through AKT signaling pathway in lung cancer
   Jeeho Kim et al, 2022, BMC Cancer CrossRef
10. Identification of allosteric inhibitor against AKT1 through structure-based virtual screening
    Keerthana Karunakaran et al, 2023, Molecular Diversity CrossRef
11. Ubenimex induces autophagy inhibition and EMT suppression to overcome cisplatin resistance in GC cells by perturbing the CD13/EMP3/PI3K/AKT/NF-κB axis
    Qie Guo et al, 2019, Aging CrossRef
12. Resistance to the platinum‑based chemotherapeutic drugs in oral cancer: Focus on the role of p22phox (Review)
    Jin-Ching Lee et al, 2024, Biomedical Reports CrossRef
13. New Cysteine Covalent Modification Strategies Enable Advancement of Proteome‐wide Selectivity of Kinase Modulators
    Ivy Guan et al, 2021, Asian Journal of Organic Chemistry CrossRef
14. Pan-Cancer Analysis Reveals Distinct Metabolic Reprogramming in Different Epithelial–Mesenchymal Transition Activity States
    Ji-Yong Sung et al, 2021, Cancers CrossRef
15. Clinical Significance of POU5F1P1 rs10505477 Polymorphism in Chinese Gastric Cancer Patients Receving Cisplatin-Based Chemotherapy after Surgical Resection
    Lili Shen et al, 2014, International Journal of Molecular Sciences CrossRef
16. Bufalin reverses intrinsic and acquired drug resistance to cisplatin through the AKT signaling pathway in gastric cancer cells
    Hongyan Zhao et al, 2016, Molecular Medicine Reports CrossRef
17. Phosphatase and Tensin Homolog (PTEN) Represses Colon Cancer Progression through Inhibiting Paxillin Transcription via PI3K/AKT/NF-κB Pathway
    Ling-Li Zhang et al, 2015, Journal of Biological Chemistry CrossRef
18. Nicotine Inhibits Cisplatin-Induced Apoptosis via Regulating α5-nAChR/AKT Signaling in Human Gastric Cancer Cells
    Yanfei Jia et al, 2016, PLOS ONE CrossRef
19. Dysregulation of mRNA profile in cisplatin-resistant gastric cancer cell line SGC7901
    Xiao-Que Xie et al, 2017, World Journal of Gastroenterology CrossRef
20. The forkhead transcription factor FOXO1 mediates cisplatin resistance in gastric cancer cells by activating phosphoinositide 3-kinase/Akt pathway
    Jinju Park et al, 2014, Gastric Cancer CrossRef